Epilepsy

• The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials (16 Sep 2024)
  
• Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy (16 Sep 2024)
  
• Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients (16 Sep 2024)
  
• Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea (16 Sep 2024)
  
• Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy (29 Aug 2024)
  
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (21 Aug 2024)
  
• Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders (20 Aug 2024)
  
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology (19 Aug 2024)
  
• An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies (24 May 2024)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures (05 Aug 2022)
  
• Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs (31 Jul 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)
  
• Epileptic seizure frequency fell by 86% in kids treated with whole plant medicinal cannabis (18 Jul 2022)